As of Feb 27
| -0.23 / -3.92%|
The 7 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 8.00. The median estimate represents a +77.30% increase from the last price of 5.64.
The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.